Literature DB >> 15319014

The ethical use of placebo in clinical trials involving children.

Albert T Derivan1, Bennett L Leventhal, John March, Mark Wolraich, Julie Magno Zito.   

Abstract

The authors reviewed various statements describing the ethical use of placebo-controls in clinical trials involving minors. Attention was focused upon the Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations, published by the American Academy of Pediatrics (AAP) (Kaufman et al. 1995). A brief review of certain key documents and a possible expansion of the guidelines are presented. Specifically, it is recommended that a review and update of guidelines for the use of placebo-controlled trials in children be undertaken by a working group comprised of stakeholders, including academic clinical and research professionals, bioethicists, consumers, members of key government agencies, and the pharmaceutical industry.

Entities:  

Keywords:  American Academy of Pediatrics; Biomedical and Behavioral Research

Mesh:

Substances:

Year:  2004        PMID: 15319014     DOI: 10.1089/1044546041649057

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  6 in total

Review 1.  Pain and placebo in pediatrics: a comprehensive review of laboratory and clinical findings.

Authors:  Kanesha Simmons; Robin Ortiz; Joe Kossowsky; Peter Krummenacher; Christian Grillon; Daniel Pine; Luana Colloca
Journal:  Pain       Date:  2014-08-29       Impact factor: 6.961

2.  When ethics constrains clinical research: trial design of control arms in "greater than minimal risk" pediatric trials.

Authors:  Inmaculada de Melo-Martín; Dolan Sondhi; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

3.  Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study.

Authors:  Elaine Tierney; Michael Aman; David Stout; Krista Pappas; L Eugene Arnold; Benedetto Vitiello; Lawrence Scahill; Christopher McDougle; James McCracken; Courtney Wheeler; Andres Martin; David Posey; Bhavik Shah
Journal:  Psychopharmacology (Berl)       Date:  2006-11-23       Impact factor: 4.530

4.  Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

Authors:  Betsy D Kennard; Susan G Silva; Taryn L Mayes; Paul Rohde; Jennifer L Hughes; Benedetto Vitiello; Christopher J Kratochvil; John F Curry; Graham J Emslie; Mark A Reinecke; John S March
Journal:  Am J Psychiatry       Date:  2009-01-15       Impact factor: 18.112

5.  A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism.

Authors:  L Eugene Arnold; Nicole Ober; Michael G Aman; Benjamin Handen; Tristram Smith; Xueliang Pan; Susan L Hyman; Jill Hollway; Luc Lecavalier; Kristin Page; Robert Rice
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-04-25       Impact factor: 2.576

6.  Considerations for adaptive design in pediatric clinical trials: study protocol for a systematic review, mixed-methods study, and integrated knowledge translation plan.

Authors:  Lauren E Kelly; Michele P Dyson; Nancy J Butcher; Robert Balshaw; Alex John London; Christine J Neilson; Anne Junker; Salaheddin M Mahmud; S Michelle Driedger; Xikui Wang
Journal:  Trials       Date:  2018-10-19       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.